| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.004 | 1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |